These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 20672371

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
    Sreeja L, Syamala V, Hariharan S, Syamala VS, Raveendran PB, Sivanandan CD, Madhavan J, Ankathil R.
    J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Safety, efficacy, and pharmacokinetics of intravenous busulfan in children undergoing allogeneic hematopoietic stem cell transplantation.
    Wall DA, Chan KW, Nieder ML, Hayashi RJ, Yeager AM, Kadota R, Przepiorka D, Mezzi K, Kletzel M, Pediatric Blood, Marrow Transplant Consortium.
    Pediatr Blood Cancer; 2010 Feb; 54(2):291-8. PubMed ID: 19743300
    [Abstract] [Full Text] [Related]

  • 25. GSTP1 and GSTA1 polymorphisms interact with cruciferous vegetable intake in colorectal adenoma risk.
    Tijhuis MJ, Wark PA, Aarts JM, Visker MH, Nagengast FM, Kok FJ, Kampman E.
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2943-51. PubMed ID: 16365014
    [Abstract] [Full Text] [Related]

  • 26. GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation.
    Jurkovic Mlakar S, Uppugunduri SCR, Nava T, Mlakar V, Golay H, Robin S, Waespe N, Rezgui MA, Chalandon Y, Boelens JJ, Bredius RGM, Dalle JH, Peters C, Corbacioglu S, Bittencourt H, Krajinovic M, Ansari M, paediatric diseases working party of the European society for blood and marrow transplantation.
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):71-86. PubMed ID: 34499222
    [Abstract] [Full Text] [Related]

  • 27. Influence of GST polymorphisms on busulfan pharmacokinetics in Japanese children.
    Nishikawa T, Yamaguchi H, Ikawa K, Nakayama K, Higashi E, Miyahara E, Abematsu T, Nakagawa S, Kodama Y, Tanabe T, Shigemi A, Shinkoda Y, Okamoto Y, Takeda Y, Kawano Y.
    Pediatr Int; 2019 Jun; 61(6):558-565. PubMed ID: 30963629
    [Abstract] [Full Text] [Related]

  • 28. Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese.
    Zhong SL, Zhou SF, Chen X, Chan SY, Chan E, Ng KY, Duan W, Huang M.
    Eur J Pharm Sci; 2006 May; 28(1-2):77-85. PubMed ID: 16488119
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics of a test dose of intravenous busulfan guide dose modifications to achieve an optimal area under the curve of a single daily dose of intravenous busulfan in children undergoing a reduced-intensity conditioning regimen with hematopoietic stem cell transplantation.
    Kletzel M, Jacobsohn D, Duerst R.
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):472-9. PubMed ID: 16545731
    [Abstract] [Full Text] [Related]

  • 30. An evaluation of busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation.
    Takamatsu Y, Ogata K, Yamauchi K, Hara S, Kamimura T, Hayashi S, Suzumiya J, Tamura K.
    Jpn J Clin Oncol; 2005 Jul; 35(7):400-3. PubMed ID: 15976066
    [Abstract] [Full Text] [Related]

  • 31. Once-daily i.v. BU-based conditioning regimen before allogeneic hematopoietic SCT: a study of influence of GST gene polymorphisms on BU pharmacokinetics and clinical outcomes in Chinese patients.
    Yin J, Xiao Y, Zheng H, Zhang YC.
    Bone Marrow Transplant; 2015 May; 50(5):696-705. PubMed ID: 25730183
    [Abstract] [Full Text] [Related]

  • 32. Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study.
    Ben Hassine K, Nava T, Théoret Y, Nath CE, Daali Y, Kassir N, Lewis V, Bredius RGM, Shaw PJ, Bittencourt H, Krajinovic M, Uppugunduri CRS, Ansari M.
    CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):1043-1056. PubMed ID: 34453497
    [Abstract] [Full Text] [Related]

  • 33. Once-daily intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics and early clinical outcomes.
    Zwaveling J, den Hartigh J, Lankester AC, Guchelaar HJ, Egeler RM, Bredius RG.
    Anticancer Drugs; 2006 Oct; 17(9):1099-105. PubMed ID: 17001185
    [Abstract] [Full Text] [Related]

  • 34. Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia.
    Baker KS, Bostrom B, DeFor T, Ramsay NK, Woods WG, Blazar BR.
    Bone Marrow Transplant; 2000 Sep; 26(6):607-14. PubMed ID: 11041565
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity.
    Zwaveling J, Bredius RG, Cremers SC, Ball LM, Lankester AC, Teepe-Twiss IM, Egeler RM, den Hartigh J, Vossen JM.
    Bone Marrow Transplant; 2005 Jan; 35(1):17-23. PubMed ID: 15502853
    [Abstract] [Full Text] [Related]

  • 37. The GSTP1 gene is a susceptibility gene for childhood asthma and the GSTM1 gene is a modifier of the GSTP1 gene.
    Kamada F, Mashimo Y, Inoue H, Shao C, Hirota T, Doi S, Kameda M, Fujiwara H, Fujita K, Enomoto T, Sasaki S, Endo H, Takayanagi R, Nakazawa C, Morikawa T, Morikawa M, Miyabayashi S, Chiba Y, Tamura G, Shirakawa T, Matsubara Y, Hata A, Tamari M, Suzuki Y.
    Int Arch Allergy Immunol; 2007 Jan; 144(4):275-86. PubMed ID: 17643058
    [Abstract] [Full Text] [Related]

  • 38. Glutathione S-transferase T1-null seems to be associated with graft failure in hematopoietic SCT.
    Elhasid R, Krivoy N, Rowe JM, Sprecher E, Efrati E.
    Bone Marrow Transplant; 2010 Dec; 45(12):1728-31. PubMed ID: 20348973
    [Abstract] [Full Text] [Related]

  • 39. The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation.
    Uppugunduri CR, Rezgui MA, Diaz PH, Tyagi AK, Rousseau J, Daali Y, Duval M, Bittencourt H, Krajinovic M, Ansari M.
    Pharmacogenomics J; 2014 Jun; 14(3):263-71. PubMed ID: 24165757
    [Abstract] [Full Text] [Related]

  • 40. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
    Zaidman I, Rowe JM, Khalil A, Ben-Arush M, Elhasid R.
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.